Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Accessing Hepatitis C Patients Who Are Difficult to Reach

Editor's pick
Medscape (requires registration)
17 December 2012
Hepatitis C treatment

Though Hepatitis C Patients Report Having Equal Influence with Their Treating Physicians Regarding the Management and Treatment of Their Disease, Very Few Have Ever Requested Specific Products for Treatment

Editor's pick
Market Watch (press release)
13 December 2012
Hepatitis C treatment

Adherence to hepatitis C treatment: unravelling the complexities

News
13 December 2012
Hepatitis C treatment

Hepatitis C Reaching Crisis Levels; Requires Coverage for Routine Screenings

Editor's pick
National Summit on HIV and Viral Hepatitis press release
28 November 2012
Hepatitis C treatment

Devon Nicholson Hep C treatment Chronicles – Week 4 – “Blood Work and Virus Tests"

Editor's pick
Net Newsledger
26 November 2012
Hepatitis C treatment

Telaprevir twice-daily works as well as every eight hours, safe for hepatitis C patients with cirrhosis

News
23 November 2012
Hepatitis C treatment

Which patients should be prioritised for new hepatitis C treatments?

News
23 November 2012
Hepatitis C treatment

Low viral load in hepatitis C treatment: Is a third drug necessary?

News
23 November 2012
Access to healthcare

Pakistan: Hepatitis C treatment: Produce cheap injections immediately, orders PAC

Editor's pick
The Express Tribune
20 November 2012
Hepatitis C transmission & prevention

Hepatits C could be eliminated from cities, leading specialist says

Editor's pick
GP Online
5 November 2012
New & experimental hepatitis C treatment

Avoiding Missteps When Evaluating New HCV Trial Data

Editor's pick
Clinical Care Options (requires registration)
5 November 2012
Access to healthcare

Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in India

Editor's pick
Lawyers' Collective
2 November 2012
Access to healthcare

IPAB revokes patent on Roche Hepatitis C drug

Editor's pick
Hindu Business Line
2 November 2012
Hepatitis C treatment

Antiviral treatment reduces risk of liver cancer in people with hepatitis C-related cirrhosis and fibrosis

News
29 October 2012
New & experimental hepatitis C treatment

Will Dropping Interferon Be the Magic Bullet for Reducing HCV Mortality?

Editor's pick
Clinical Care Options (requires registration)
26 October 2012
Hepatitis C treatment

Hepatitis C – What Are My Options for Treatment? New Webinar

Editor's pick
American Liver Foundation
25 October 2012
Hepatitis C symptoms & diagnosis

Egypt launches world’s largest Hepatitis C patient registry

Editor's pick
Ahram Online
22 October 2012
New & experimental hepatitis C treatment

HCV Advocates Survey

Editor's pick
Treatment Action Group
15 October 2012
Hepatitis C treatment

Prior Alcohol Consumption Does Not Impair HCV Treatment

Editor's pick
HCV New Drugs Research
12 October 2012
Hepatitis C treatment

Vitamin D deficiency associated with a poorer response to HCV treatment in HIV/HCV-co-infected patients

News
11 October 2012
Hepatitis C treatment

Mental Health in Hepatitis C: A European Expert Consensus Statement

Editor's pick
European Liver Patients Association
9 October 2012
Hepatitis C treatment

Treatment of hepatitis C can be successful in a prison population

Editor's pick
News-Medical.net
9 October 2012
Hepatitis C treatment

Don't rule out IFN/ribavirin for HIV patients with hep C cirrhosis: study

Editor's pick
HCV New Drugs Research
3 October 2012
Hepatitis C treatment

Higher levels of adherence to hepatitis C therapy improve treatment outcomes in people with hepatitis C and HIV

News
3 October 2012